Menu

Researchers Mine Centipede Toxins for Analgesics

Venomous centipedes may harbor a clue to the creation of a successful pain-killing compound for humans.

Jan 1, 2018
Catherine Offord

ELVIND UNDHEIM

Centipede venom has a long history as a painkiller—toxins from the Chinese red-headed centipede (Scolopendra subspinipes mutilans) have been used in Chinese medicine for hundreds of years. But the leggy creature’s arsenal has only recently gained attention as inspiration for modern analgesics. “There’s on the order of 3,000 venomous centipedes,” says Glenn King, a biochemist at the University of Queensland, Australia. “Yet they’re massively underexplored in terms of what’s in the venom.”

In 2013, King and colleagues reported that one centipede-made peptide, Ssm6a, selectively inhibits NaV1.7—a voltage-gated sodium channel implicated in pain sensing in mammals, including humans (PNAS, 110:17534-39). In rodent models, Ssm6a was more potent than morphine, though the finding has yet to be reproduced. Last year, a Chinese team showed that another centipede peptide, potassium channel blocker SsmTX-I, has analgesic properties in mice (J Ppt Sci, 23:384-91, 2017).

“These venoms are full of ion-channel modulators,” says King. From a pain-killing perspective, “some of those molecules may turn out to be more or less useful therapeutically—we just don’t know yet.”

Read about other animal groups researchers are exploring for pain-killing leads in the full feature story, “Animal Analgesics.”

July/August 2019

On Target

Researchers strive to make individualized medicine a reality

Marketplace

Sponsored Product Updates

DNASTAR® announced the release of Lasergene 16 Software
DNASTAR® announced the release of Lasergene 16 Software
DNASTAR® announced the release of Lasergene 16 today, which includes a broad range of improvements in for analysis of DNA, RNA and protein sequence data, as well as new advancements for predicting and analyzing protein structures. 
Arbor Biosciences Partners with Curio Genomics for Analysis of IWGSC Wheat Exome
Arbor Biosciences Partners with Curio Genomics for Analysis of IWGSC Wheat Exome
Arbor Biosciences, a division of Chiral Technologies, Inc and worldwide leader in next generation sequencing (NGS) target enrichment, announces a partnership with Curio Genomics for bioinformatics analysis of the wheat genome.
IDT and Washington University join forces to increase access to the latest NGS technologies
IDT and Washington University join forces to increase access to the latest NGS technologies
As part of its commitment to advocate for the genomics age, Integrated DNA Technologies (IDT) aims to lower the barriers to access the latest NGS technologies.
Bio-Rad Launches Bio-Plex Pro Human Immunotherapy Panel 20-plex Multiplex Assay, a targeted tool for researching signaling networks in Immunotherapy Research
Bio-Rad Launches Bio-Plex Pro Human Immunotherapy Panel 20-plex Multiplex Assay, a targeted tool for researching signaling networks in Immunotherapy Research
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) July 15, 2019 announced the launch of its Bio-Plex Pro Human Immunotherapy Panel 20-plex, a multiplex immunoassay that offers a targeted approach for Immunotherapy Research.